Adenomatous polyposis coli (APC) is a rare inherited condition that causes hundreds to thousands of small growths, called polyps, to develop throughout the colon and rectum, often beginning during the teenage years. Without treatment, these polyps almost certainly transform into cancer, making early diagnosis and careful management essential for preserving health and extending life.

How Treatment Aims to Prevent Cancer and Protect Life

When someone receives a diagnosis of familial adenomatous polyposis, the primary goal of treatment is to prevent colorectal cancer from developing. This condition, caused by mutations in the adenomatous polyposis coli gene, creates an environment in the bowel where cancer becomes almost inevitable without intervention. The treatment approach focuses on removing the colon before cancer can take hold, while also monitoring other parts of the body where polyps and tumors might appear.^[1]

Treatment decisions depend heavily on the person’s age, the number and characteristics of polyps, whether cancer has already developed, and the individual’s overall health. Medical societies have established clear guidelines based on decades of research, recommending that most people with this condition undergo surgery to remove the colon at an appropriate time—usually during late adolescence or early adulthood. This surgery dramatically reduces the risk of colorectal cancer and can be life-saving.^[2]

Beyond surgery, treatment involves lifelong monitoring for polyps and tumors that can develop in the stomach, small intestine, and other organs. Research continues into new therapies that might reduce polyp formation or delay surgery, including medications that target the biological pathways involved in polyp growth. Clinical trials are testing innovative approaches that could one day change how this condition is managed.^[4]

Standard Treatment Approaches That Medical Guidelines Recommend

The cornerstone of standard treatment for familial adenomatous polyposis is surgical removal of the colon. Doctors typically recommend this surgery when polyps begin appearing in large numbers, which usually happens during the teenage years or early twenties. The timing of surgery is carefully chosen to balance cancer risk against allowing the person to reach an appropriate psychological and physical maturity for such a major operation.^[7]

There are several surgical options available. Total colectomy involves removing the entire colon while leaving the rectum in place, then connecting the small intestine to the remaining rectum. This approach requires continued monitoring of the rectum, as polyps will continue to form there. Another option is proctocolectomy, which removes both the colon and rectum, then creates an internal pouch from the small intestine to serve as a new rectum. This eliminates most of the cancer risk but requires more extensive surgery and adaptation to changes in bowel function.^[2]

The choice between surgical approaches depends on several factors, including how many polyps are present in the rectum, whether the person can commit to regular rectal surveillance if the rectum is preserved, and the risk of developing desmoid tumors—tough, fibrous growths that can occur in the abdomen and are more common after surgery in people with this condition. About 10 to 30 percent of people with familial adenomatous polyposis develop desmoid tumors, which can cause serious complications even though they are not cancerous.^[11]

After surgery, people need regular examinations of the remaining digestive tract. If the rectum was preserved, examinations every three to six months are necessary to remove any new polyps that develop. If an internal pouch was created, it also requires regular monitoring, as polyps can form in the pouch tissue itself.^[12]

Surveillance of the upper digestive tract is equally important. Polyps frequently develop in the duodenum—the first part of the small intestine where the stomach empties—and around the ampulla of Vater, where digestive enzymes enter the intestine. These areas carry an 8 percent lifetime risk of cancer. Doctors perform upper endoscopy examinations every one to three years, using both front-viewing and side-viewing scopes to carefully examine these areas. Large or suspicious polyps can be removed during these examinations.^[2]

Medical therapy plays a supporting role in treatment. Certain medications, particularly nonsteroidal anti-inflammatory drugs such as sulindac and celecoxib, have been shown to reduce the number and size of polyps in some people. These drugs work by inhibiting enzymes called cyclooxygenases that are involved in inflammation and polyp growth. However, these medications are not effective enough to be used alone instead of surgery. They may help delay surgery in some cases or reduce polyp formation after surgery, but they carry their own risks, including increased chances of heart problems with long-term use of celecoxib.^[12]

The duration of treatment is lifelong. Even after successful surgery to remove the colon, people with familial adenomatous polyposis need regular surveillance for the rest of their lives. This includes annual examinations of the upper digestive tract, monitoring for desmoid tumors through physical examination or imaging, and screening for thyroid cancer, which occurs in 2 percent of people with this condition. Women with familial adenomatous polyposis should begin thyroid cancer screening in their teenage years, as thyroid cancer tends to develop earlier in this population.^[2]

Side effects from surgery can be significant and require adaptation. After colon removal, most people experience more frequent bowel movements—often four to six times daily or more. Some people have difficulty controlling bowel movements, particularly at night. Dietary adjustments, medications to slow bowel transit, and pelvic floor exercises can help manage these changes. Sexual function and fertility can be affected in some cases, particularly after extensive pelvic surgery. Discussing these potential effects with the surgical team before the operation helps people prepare and make informed decisions.^[11]

Promising Therapies Being Tested in Clinical Trials

Research into new treatments for familial adenomatous polyposis continues actively, with several promising approaches being evaluated in clinical trials around the world, including in the United States, Europe, and other regions. These studies aim to find ways to reduce polyp formation, delay the need for surgery, or better manage polyps after surgery.^[15]

One area of investigation focuses on medications that target the Wnt signaling pathway, a molecular cascade that becomes overactive when the APC gene is mutated. The normal APC protein helps regulate this pathway, which controls cell growth and division in the intestinal lining. When the APC protein is defective, the Wnt pathway remains constantly activated, driving excessive cell multiplication and polyp formation. Researchers are testing drugs that can block different points in this pathway, potentially slowing or stopping polyp development. These investigations are primarily in Phase I and Phase II trials, examining whether these drugs are safe and whether they can reduce polyp numbers in patients.^[16]

Another research direction explores combination therapies using different classes of anti-inflammatory medications together. Since inflammation plays a role in polyp development, combining drugs that work through different mechanisms might provide better polyp suppression than single drugs alone. Early Phase II trials are investigating whether such combinations can safely reduce polyp burden enough to delay surgery in younger patients or reduce polyp formation in the remaining rectum or internal pouch after surgery.^[12]

Some clinical trials are examining whether medications already approved for other conditions might help people with familial adenomatous polyposis. For example, drugs called EGFR inhibitors, which block a protein involved in cell growth, are being studied to see if they can reduce polyp formation in the duodenum, where polyps are difficult to manage surgically. These trials typically enroll patients who have already had their colon removed but continue to develop troublesome upper intestinal polyps. The goal is to find ways to control polyp growth in areas where surgery is more risky or complicated.^[15]

Advanced endoscopic techniques are also being evaluated as alternatives to traditional surgery in selected patients. Some research centers are testing whether repeated, intensive polyp removal using sophisticated endoscopic tools can safely manage rectal polyps in people who have had their colon removed but still have their rectum. If successful, this approach might allow some people to keep their rectum longer or avoid the need for a second surgery. These studies carefully monitor participants to ensure that no cancerous changes are missed during the surveillance process.^[16]

Clinical trial eligibility typically depends on several factors. Most trials require genetic confirmation of the APC mutation, documentation of polyp numbers and characteristics through endoscopy, and assessment of whether the person has already undergone colon removal surgery. Some trials specifically seek younger patients who have not yet had surgery, while others focus on adults who have had surgery but continue to develop polyps in remaining intestinal tissue. Geographic location can affect access to trials, though some studies have multiple sites across different countries to increase participation opportunities.^[15]

Preliminary results from some of these trials have shown modest benefits. For instance, early studies of certain Wnt pathway inhibitors have demonstrated reductions in polyp size or numbers in some participants, along with acceptable safety profiles. However, none of these experimental therapies have yet proven effective enough to replace surgery as the primary treatment. Research continues to refine these approaches and identify which patients might benefit most from specific therapies.^[16]

Most common treatment methods

• Surgical removal of the colon (Colectomy)
  • Total colectomy removes the entire colon while preserving the rectum, which requires ongoing surveillance for polyps that continue to form
  • Proctocolectomy removes both colon and rectum, with creation of an internal pouch from small intestine to serve as new rectum
  • Surgery typically performed during late teenage years or early twenties when polyps become numerous
  • Timing balances cancer risk against patient’s psychological and physical readiness for major surgery
  • Reduces colorectal cancer risk dramatically but requires adaptation to changes in bowel function
• Endoscopic surveillance and polyp removal
  • Flexible sigmoidoscopy or colonoscopy performed annually starting at age 10-12 years to detect polyp development
  • After colon surgery, remaining rectum or internal pouch examined every 3-6 months to remove new polyps
  • Upper endoscopy of stomach and duodenum performed every 1-3 years to monitor and remove upper intestinal polyps
  • Both front-viewing and side-viewing endoscopes used to examine ampulla of Vater where polyps commonly develop
• Anti-inflammatory medications
  • Sulindac and celecoxib can reduce number and size of polyps in some patients
  • Work by inhibiting cyclooxygenase enzymes involved in inflammation and polyp growth
  • Not effective enough to replace surgery as primary treatment
  • May help delay surgery or reduce polyp formation after surgery in selected cases
  • Long-term use of celecoxib carries increased risk of cardiovascular problems
• Screening for associated cancers
  • Annual thyroid examination and ultrasound, particularly for women, starting in teenage years
  • Monitoring for desmoid tumors through physical examination and imaging when symptoms occur
  • Screening for pancreatic, liver, and brain cancers in selected high-risk individuals
  • Upper gastrointestinal surveillance addresses 8% lifetime risk of duodenal cancer
• Genetic testing and counseling
  • Blood test identifies APC gene mutations in affected individuals and at-risk family members
  • Determines which family members need surveillance and which do not carry the mutation
  • Helps guide timing and type of surgery based on specific gene mutation location
  • Provides information for family planning decisions